| Patents for C07C 323 - Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups (27,160) |
|---|
| 09/30/2003 | US6627774 N-deacetylthiocolchicine derivatives and pharmaceutical compositions containing them |
| 09/30/2003 | US6627773 Process for producing 2-hydroxy-4-methyl-thiobutanoic acid |
| 09/30/2003 | US6627686 Mixture with rubber; oxidation resistance; tires, rolls, conveyor belts, footwear |
| 09/25/2003 | WO2003078393A2 Fluorinated phenyl thiophenyl derivatives and their use for imaging serotonin transporters |
| 09/25/2003 | WO2003078390A1 Phenolic compound and recording material containing the same |
| 09/25/2003 | WO2003078382A1 N-biphenylamides and fungicidal compositions containing the same |
| 09/25/2003 | WO2003077847A2 Substituted amides |
| 09/25/2003 | WO2003029199A9 Benzene derivatives, process for preparing the same and use thereof |
| 09/25/2003 | WO2003010128A3 Perfluoroalkyl-substituted amines, acids, amino acids and thioether acids |
| 09/25/2003 | WO2002100818A3 Aminediols as agents for the treatment of alzheimer's disease |
| 09/25/2003 | WO2002030884A3 Sulfide and disulfide compounds and compositions for cholesterol management and related uses |
| 09/25/2003 | WO2002030882A3 Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses |
| 09/25/2003 | US20030181759 Reacting a benzoic acid with a halogenating agent in presence of palladium catalyst to form halogenated benzoic acid or derivatives |
| 09/25/2003 | US20030181726 Aminoalcohol derivatives and their use as beta 3 adrenergic agonists |
| 09/25/2003 | US20030181491 C2-disubstituted indan-1-ol compounds, their derivatives, processes for their preparation, and their use as pharmaceuticals |
| 09/25/2003 | US20030181391 Dipeptide apoptosis inhibitors and the use thereof |
| 09/25/2003 | US20030181390 Sustained release of aminobutyric acid using prodrugs such as L-1-naphthylalanine-gabapentin, administered for prophylaxis of nervous system disorders, as anxiolytics, antidepressants or antiinflammatory agents; drug delivery |
| 09/24/2003 | EP1345897A1 Chemical process and new intermediates |
| 09/24/2003 | EP1345891A1 Glucagon antagonist/inverse agonist |
| 09/24/2003 | EP0984959B1 Aromatic sulfonyl alpha-hydroxy hydroxamic acid compounds |
| 09/24/2003 | CN1444580A Method for producing lipoic acid and dihydrolipoic acid |
| 09/24/2003 | CN1444573A Carboxamide compounds and their use as antagonists of human 11CBY receptor |
| 09/23/2003 | US6624188 Method of treatment with compounds having retinoid-like activity and reduced skin toxicity and lacking teratogenic effects |
| 09/23/2003 | US6624152 Inhibition and prevention of cell adhesion and cell adhesion-mediated pathologies. This invention relates to pharmaceutical formulations comprising these compounds and methods of using them for inflammatory and autoimmune diseases |
| 09/23/2003 | US6623655 Nitrilotriacetic acid derivatives; improved specificity and stability; protein purification, detection and/or binding |
| 09/23/2003 | CA2127110C Carbamates and crop protection agents containing them |
| 09/23/2003 | CA2098122C Anti-atherosclerotic aryl compounds |
| 09/23/2003 | CA2074385C Pleuromutilin complexes |
| 09/18/2003 | WO2003076450A1 Catalysts for olefin polymerization |
| 09/18/2003 | WO2003076406A1 Nitrosodiphenylamine derivatives and their pharmaceutical use against oxidative stress pathologies |
| 09/18/2003 | WO2003076397A1 Aminoalcohol derivatives as beta-3 adrenergic receptor agonists |
| 09/18/2003 | WO2003075907A2 Small molecule entry inhibitors |
| 09/18/2003 | WO2003075857A2 Amino-methyl substituted tetracycline compounds |
| 09/18/2003 | WO2003075853A2 Cyclic derivatives as modulators of chemokine receptor activity |
| 09/18/2003 | WO2003053915A3 Compounds for the treatment of inflammatory disorders |
| 09/18/2003 | WO2003051893A3 Improvements in pharmaceutical compositions |
| 09/18/2003 | WO2003051807A3 Improvements in pharmaceutical compositions |
| 09/18/2003 | WO2002076925A3 Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses |
| 09/18/2003 | WO2002062750A9 Cannabinoid receptor ligands |
| 09/18/2003 | US20030176747 Process for the production of fluorinated organic compounds and fluorinating agents |
| 09/18/2003 | US20030176670 Multivalent macrolide antibiotics |
| 09/18/2003 | US20030176497 Carboxamide-substituted phenylurea derivatives, process for their preparation and their use as medicaments |
| 09/18/2003 | US20030176485 Calcium receptor active compounds |
| 09/18/2003 | US20030176324 Derivatives of water insoluble drugs which exhibit good activity and water solubility |
| 09/18/2003 | US20030175848 For use as alternative substrates for NAD(P)H-dependent disulphide-reductase enzymes such as trypanothion reductase and thioredoxine reductase |
| 09/18/2003 | US20030172470 Intense, stable blue color shades can be obtained in addition to natural and purple or violet shades. |
| 09/18/2003 | CA2479065A1 Aminoalcohol derivatives as beta-3 adrenergic receptor agonists |
| 09/18/2003 | CA2478652A1 Nitrosodiphenylamine derivatives and their pharmaceutical use against oxidative stress pathologies |
| 09/17/2003 | EP1344525A1 Aniline derivatives or salts thereof and cytokine production inhibitors containing the same |
| 09/17/2003 | EP1343805A1 Bile-acid derived compounds for providing sustained systemic concentrations of drugs after oral administration |
| 09/17/2003 | EP1343751A2 Cyclic derivatives as modulators of chemokine receptor activity |
| 09/17/2003 | EP0906293B1 Substituted sulphonyl amino(thio)carbonyl compounds and their use as herbicides |
| 09/17/2003 | EP0891329B1 Peptidyl compounds having mmp and tnf inhibitory activity |
| 09/17/2003 | EP0769940B1 INDENE sPLA2 INHIBITORS |
| 09/17/2003 | EP0668762B1 Isobutenyl-substituted taxanes and their pharmaceutical compositions |
| 09/17/2003 | CN1443179A Aniline derivatives |
| 09/17/2003 | CN1443156A Preparation of 4-thioalkylbromobenzene derivatives |
| 09/17/2003 | CN1443155A Compounds to treat alzheimer's disease |
| 09/17/2003 | CN1443137A Chemical process |
| 09/17/2003 | CN1121383C Process for recycle of waste product of diltiazem synthesis |
| 09/17/2003 | CN1121376C Substituted 4-biarylbutyric or 5-biarylpentanoic acids and derivatives and matrix metalloprotease inhibitors |
| 09/16/2003 | US6620961 Biarylalkylenecarbamic acid derivatives and bacteriocides for agricultural and horticultural use |
| 09/16/2003 | US6620927 Biscarbodiimides, bisthiourea derivatives, bisurea derivatives having a disulfide bond; crosslinking hyaluronic acids and dervivatives to form high viscosity sustained release, drug delivery agents; eye surgery; tissue engineering |
| 09/16/2003 | US6620848 Nitric oxide synthase inhibitors |
| 09/16/2003 | US6620813 Hydroxamate derivatives of non-steroidal anti-inflammatory drugs |
| 09/16/2003 | US6620776 Detergent additive composition and processes therefore and therewith |
| 09/16/2003 | CA2107219C S-nitrosothiols as smooth muscle relaxants and therapeutic uses thereof |
| 09/16/2003 | CA2105683C N-¬¬4,5-dihydroxy-and 4,5,8-trihydroxy-9,10-dihydro-9, 10-dioxo-2-anthracene-yl|carbonyl|amino acids useful in the therapy of osteoarticular affections |
| 09/12/2003 | WO2003074990A2 Artificial receptors, building blocks, and methods |
| 09/12/2003 | WO2003074476A1 Novel arylamidine derivative or salt thereof |
| 09/12/2003 | WO2003074038A1 Methods for treating diseases related to intraocular pressure |
| 09/12/2003 | WO2002002684A9 Stabilisers, in particular for thermoplastic polyurethanes |
| 09/12/2003 | CA2477749A1 Artificial receptors, building blocks, and methods |
| 09/12/2003 | CA2477392A1 Methods for treating diseases related to intraocular pressure |
| 09/11/2003 | US20030171596 Synthesis of epothilones, intermediates thereto, analogues and uses thereof |
| 09/11/2003 | US20030171585 Anti-inflammatory compounds |
| 09/11/2003 | US20030171435 New amphetamine derivatives, antibodies against them and pharmaceutical compositions containing them |
| 09/11/2003 | US20030171422 Aldose reductase inhibitors; antidiabetic agents |
| 09/11/2003 | US20030170381 Piezoelectric element and process for production thereof |
| 09/10/2003 | EP1341773A2 Substituted 1,3,5-triazines and pyrimidines as abca-1 elevating compounds against coronary artery disease or atherosclerosis |
| 09/10/2003 | EP1341755A1 Carboxylic acid amide derivatives and their use in the treatment of thromboembolic diseases and tumours |
| 09/10/2003 | EP1157987B1 S-nitrosothiols as agents for the treatment of circulatory dysfunctions |
| 09/10/2003 | EP1140818B1 Amidomalonamides and their use as inhibitors of matrix metalloproteinase |
| 09/10/2003 | EP1091948B9 Tubulin binding compounds (cobra) |
| 09/10/2003 | EP1046634B1 Processes for producing beta-halogeno-alpha-amino-carboxylic acids and phenylcysteine derivatives and intermediates thereof |
| 09/10/2003 | EP0939627B1 Pentafluorobenzenesulfonamides and analogs |
| 09/10/2003 | EP0896533B1 Pentafluorobenzenesulfonamides and analogs |
| 09/10/2003 | EP0809647B1 Chiral organometallic compounds |
| 09/10/2003 | CN1441778A Pleuromutilin derivatives having antibacterial activity |
| 09/10/2003 | CN1441773A Cyclohexylamine derivative as subtype selective NMDA receptor Antagonists |
| 09/10/2003 | CN1441770A Modified forms of pharmacologically active agents and uses therefor |
| 09/10/2003 | CN1120834C Process for preparation of 3-(mehylthion) propanaldehyde and 2-hydroxy-4-(meghylthion) butanoic acid |
| 09/09/2003 | US6617414 Polymerizable to polybenzothiazoles and polybenzoxazoles; storage stability; high strength, heat resistant fibers and films; white particles of specific size |
| 09/09/2003 | US6617352 Compounds and methods for the inhibition of the expression of VCAM-1 |
| 09/04/2003 | WO2003072614A2 Thiol compound, photopolymerization initiator composition and photosensitive composition |
| 09/04/2003 | WO2003072597A1 Intermediates and methods for making heptapeptide oxytocin analogues |
| 09/04/2003 | WO2003072537A2 Selective protein tyrosine phosphatatase inhibitors |
| 09/04/2003 | WO2003030812A3 1-[(4-methyl thio)phenyl]-2-(phenyl acetoxy)-1-ethanone and a process for preparing the same |
| 09/04/2003 | WO2002032376A3 Bile-acid conjugates for providing sustained systemic concentrations of drugs |
| 09/04/2003 | US20030166971 Bromination of thioanisol in alcoholic solvent |